122 related articles for article (PubMed ID: 128845)
1. Enhanced anticlotting activity of fragments D formed during plasmin hydrolysis of fibrinogen in the presence of calcium chloride.
Belitser VA; Varetska TV; Tolstykh VM; Tsaryuk LA; Pozdnyakova TM
Thromb Res; 1975 Nov; 7(5):797-806. PubMed ID: 128845
[No Abstract] [Full Text] [Related]
2. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y).
Nieuwenhuizen W; Voskuilen M; Hermans J
Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917
[TBL] [Abstract][Full Text] [Related]
3. The cleavage of beta-chain in bovine fibrinogen DH fragment (95 kDa) leads to a significant increase in its anticlotting activity.
Medved LV; Platonova TN; Litvinovich SV; Lukinova NI
FEBS Lett; 1988 May; 232(1):56-60. PubMed ID: 2966748
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen degradation by two neutral granulocyte proteinases. Influence of calcium on the generation of fibrinogen degradation products with anticlotting properties.
Bingenhkeimer C; Gramse M; Egbring R; Havemann K
Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):853-63. PubMed ID: 6456216
[TBL] [Abstract][Full Text] [Related]
5. Anticlotting properties of fragments D from human fibrinogen and fibrin.
Haverkate F; Timan G; Nieuwenhuizen W
Eur J Clin Invest; 1979 Aug; 9(4):253-5. PubMed ID: 118016
[TBL] [Abstract][Full Text] [Related]
6. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
7. [Effect of fragments E and D on the plasmin hydrolysis of the fibrin clot].
Lezhen TI; Kudinov SA
Biokhimiia; 1986 Jun; 51(6):967-9. PubMed ID: 2942191
[TBL] [Abstract][Full Text] [Related]
8. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).
Nieuwenhuizen W; Gravesen M
Biochim Biophys Acta; 1981 Mar; 668(1):81-8. PubMed ID: 6453618
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the plasmin digestion products of fibrinogen and fibrin by calcium ions.
Purves LR; Lindsey GG; Brown G; Franks J
Thromb Res; 1978 Mar; 12(3):473-84. PubMed ID: 148750
[No Abstract] [Full Text] [Related]
11. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
12. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Carroll RC; Lockhart MS; Taylor FB
J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
[TBL] [Abstract][Full Text] [Related]
13. A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties.
Nieuwenhuizen W; Voskuilen M; Vermond A; Haverkate F; Hermans J
Biochim Biophys Acta; 1982 Oct; 707(2):190-2. PubMed ID: 7138883
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin.
Nieuwenhuizen W; Vermond A; Haverkate F
Biochim Biophys Acta; 1981 Feb; 667(2):321-7. PubMed ID: 6452172
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
Belitser VA; Lugovskoy EV; Musjalkovskaja AA; Gogolinskaja GK
Thromb Res; 1982 Aug; 27(3):261-9. PubMed ID: 6291191
[TBL] [Abstract][Full Text] [Related]
16. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
17. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
Triantaphyllopoulos E
Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
[No Abstract] [Full Text] [Related]
18. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
[TBL] [Abstract][Full Text] [Related]
19. The role of the lysine binding sites of human plasmin in the hydrolysis of human fibrinogen.
Morris JP; Castellino FJ
Biochim Biophys Acta; 1983 Apr; 744(1):99-104. PubMed ID: 6219709
[TBL] [Abstract][Full Text] [Related]
20. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
Regañon E; Aznar J; Vila V
Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
